Entrepreneurs Investment Meet
Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. Supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.
Related Conference of Entrepreneurs Investment Meet
20th International Conference on Allergic Diseases and Clinical Immunology
6th International conference on Vaccines, Vaccination and Immunization
Entrepreneurs Investment Meet Conference Speakers
Recommended Sessions
- Antibiotics Alternative
- Antibiotic Prophylaxis
- Antibiotic Resistance
- Antibiotics
- Antibiotics and Public Health
- Antibiotics: Industrial Scope
- Antimicrobial
- Application of Antibiotics
- Current Challenge and Market
- Drug Discovery
- Entrepreneurs Investment Meet
- Immunology
- Interaction of Antibiotics
- Mechanism : Antibiotics
- Next Generation Approach
- Oncology Antibiotics
- Pediatric Antibiotics
- Types of Antibiotics
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Italy)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Italy)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Italy)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Italy)
- Epidemiology - European Immunology 2025 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (France)
- Immunodeficiency - European Immunology 2025 (France)
- Immunogenetics - European Immunology 2025 (France)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (France)
- Immunological Techniques - European Immunology 2025 (France)
- Immunology - European Immunology 2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Italy)
- Immunotherapy - European Immunology 2025 (France)
- Immunotoxicology - European Immunology 2025 (France)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Italy)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology - European Immunology 2025 (France)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Italy)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Italy)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Italy)
- Parasite Immunology - European Immunology 2025 (France)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (France)
- Reproductive Immunology - European Immunology 2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Italy)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Italy)
- Transplantation Immunology - European Immunology 2025 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (France)